Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 07, 2021

SELL
$14.49 - $20.72 $9,795 - $14,006
-676 Closed
0 $0
Q4 2020

Jan 13, 2021

BUY
$14.61 - $22.14 $7,509 - $11,379
514 Added 317.28%
676 $14,000
Q3 2020

Nov 12, 2020

SELL
$13.67 - $17.77 $2,898 - $3,767
-212 Reduced 56.68%
162 $2,000
Q2 2020

Aug 13, 2020

SELL
$10.89 - $21.47 $21,409 - $42,210
-1,966 Reduced 84.02%
374 $6,000
Q1 2020

May 12, 2020

BUY
$10.23 - $24.56 $22,997 - $55,210
2,248 Added 2443.48%
2,340 $27,000
Q4 2019

Feb 07, 2020

BUY
$17.42 - $26.61 $731 - $1,117
42 Added 84.0%
92 $2,000
Q3 2019

Nov 14, 2019

BUY
$16.36 - $21.39 $818 - $1,069
50 New
50 $1,000

Others Institutions Holding HRTX

About HERON THERAPEUTICS, INC.


  • Ticker HRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,774,000
  • Market Cap $210M
  • Description
  • Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...
More about HRTX
Track This Portfolio

Track Sowell Financial Services LLC Portfolio

Follow Sowell Financial Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sowell Financial Services LLC with notifications on news.